FCL

Fineotex Chemical share price & financials

Price
₹43.52
Market cap
₹4.8k Cr
Sector
Chemicals
Calls analysed
7
Latest concall · Q1 FY27 · call held 24 Jul 2026

Fineotex Chemical Limited Q1 FY27

EBITDA ₹59.14 cr +135%EBITDA Margin 15.7% PAT ₹48.21 cr +93%Gross Margin 35.42%

What went well

  • Total income for Q1 FY27 stood at INR 386.72 crores, registering a 165% year-on-year growth.
  • EBITDA for the quarter was INR 59.14 crores, a 134.7% Y-o-Y growth, with EBITDA margin at 15.70% (up from 13.93% last quarter).
  • PAT increased by 92.67% Y-o-Y to INR 48.21 crores.

What to watch

  • The Indian textile business showed a marginal decline (1-2% dip) in Q1 FY27, attributed to seasonality and competition.
Read the full call →

What Fineotex Chemical Limited does

Fineotex Chemical manufactures tailor-made speciality performance chemicals used in textile wet-processing (pre-treatment, dyeing, printing, finishing), oilfield drilling and production (demulsifiers, corrosion inhibitors, biocides, surfactants), water treatment (scale-inhibiting polymers) and FMCG cleaning & hygiene products (floor cleaners, hand-washes, sanitizers, dishwashers). It earns by selling these customized chemical formulations to industrial customers through its own manufacturing plants and a dealer network across India and international markets. The group expanded into North American oilfield chemicals in December 2025 through a controlling stake in US-based CrudeChem Technologies Group, and runs its textile R&D through Malaysian subsidiary Biotex.

Segments

  • Textile Specialty Chemicals
  • Oil & Gas (Drilling & Oilfield Specialty Chemicals)
  • Water Treatment
  • FMCG, Cleaning & Hygiene
Manufacturing plants
5 plants across India (Mahape, Ambernath), Malaysia (Selangor) and USA (Brookshire and Midland, Texas)
Combined installed manufacturing capacity
~2,00,000 MTPA
Countries with sales presence
~70 countries
Product categories
470+
SKUs across product categories
1,600+
Dealer network
103+ dealers across Indian and international markets
Founded 2004Headquarters Mumbai, Maharashtra, India Company website

Guidance record · Q1 FY27

what the last two calls moved 14 tracked 3 delivered 2 missed 9 open
  • CrudeChem EBITDA Margin delivered said Q3 FY26 Promised: Always double digits going forward (up from historical 7-8%) Q1 FY27: New guidance for CrudeChem EBITDA margin is 13-14%, confirming the 'double digits' target is being met.
  • AquaStrike Premium Revenue went quiet said Q3 FY25 Promised: Substantial business from April onwards (Q1 FY26) Q1 FY27: No mention of AquaStrike in the earnings call or investor presentation.
  • EBITDA Margin on track said Q4 FY25 Promised: Around 24% going forward Q1 FY27: Actual margin 15.7%, up from 14% last quarter. Progressing towards 18-20% target.

All 14 tracked — every revision, and every one management stopped mentioning.

Open the guidance ledger

Quarterly results

Q1 FY27: revenue up 175.2%, net profit up 92.0% against the same quarter last year.

₹ Cr · quarterly
Line itemQ2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Revenue146 126 120 137 138 −5%184 +46%314 +162%377 +175%
EBITDA36 34 21 25 31 −14%35 +3%44 +110%59 +136%
Net profit32 28 20 25 26 −19%30 +7%44 +120%48 +92%
How to read this

₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.

Performance −76.2% 1Y

₹50₹100₹150₹200₹250Sept 25Oct 25Dec 25Jan 26Mar 26Apr 26Jun 26Jul 26Sept 26Q2 FY26 — 10 Dec 2025Q3 FY26 — 16 Feb 2026Q4 FY26 — 18 May 2026Q1 FY27 — 24 Jul 2026

1Y: ₹242.35 on 10 Sept 2025 → ₹57.72. High ₹257.32 (29 Sept 2025), low ₹19.24 (30 Mar 2026).

How the price took the results

close before → close after

Q1 FY27
−5.5%
24 Jul
Q4 FY26
+20.0%
18 May
Q3 FY26
+0.6%
16 Feb
Q2 FY26
−2.1%
10 Dec

The move from the last close before each results date to the first close after it — the market's first read on the quarter, not the quarter itself.

Financials, as filed

Revenue grew 14.3% a year over 3 years, FY23 to FY26. Operating margin narrowed to 17.5%.

Year endingFY23FY24FY25FY26
Revenue₹517 Cr₹568 Cr₹534 Cr₹773 Cr
Operating profit₹113 Cr₹148 Cr₹126 Cr₹135 Cr
Operating margin21.9%26.1%23.6%17.5%
Interest₹0 Cr₹1 Cr₹0 Cr₹1 Cr
Depreciation₹4 Cr₹5 Cr₹9 Cr₹13 Cr
Net profit₹89 Cr₹120 Cr₹109 Cr₹125 Cr
Net margin17.2%21.1%20.4%16.2%
Cash from operations₹107 Cr₹97 Cr₹69 Cr₹-24 Cr
Free cash flow₹88 Cr₹49 Cr₹1 Cr₹-49 Cr
ROCE36.0%39.0%24.0%18.0%
How to read this

From the company's own filings. Margins are computed from the filed sums; a year with an incomplete quarter is left blank rather than estimated.

Balance sheet

Year endingFY21FY22FY23FY24FY25FY26
Equity capital₹22 Cr₹22 Cr₹22 Cr₹22 Cr₹23 Cr₹116 Cr
Reserves₹187 Cr₹240 Cr₹327 Cr₹425 Cr₹756 Cr₹766 Cr
Borrowings₹3 Cr₹2 Cr₹7 Cr₹5 Cr₹0 Cr₹8 Cr
Other liabilities₹54 Cr₹75 Cr₹67 Cr₹96 Cr₹98 Cr₹269 Cr
Total liabilities₹267 Cr₹339 Cr₹423 Cr₹548 Cr₹878 Cr₹1.2k Cr
Fixed assets₹59 Cr₹84 Cr₹99 Cr₹141 Cr₹198 Cr₹278 Cr
Capital work in progress₹5 Cr₹0 Cr₹0 Cr₹0 Cr₹8 Cr₹2 Cr
Investments₹32 Cr₹17 Cr₹89 Cr₹147 Cr₹348 Cr₹317 Cr
Other assets₹171 Cr₹238 Cr₹234 Cr₹260 Cr₹323 Cr₹562 Cr
Total assets₹267 Cr₹339 Cr₹423 Cr₹548 Cr₹878 Cr₹1.2k Cr
How to read this

As filed each year. A line the company does not report — deposits for a non-lender, for instance — is left out rather than shown as a row of dashes.

Mutual funds in FCL

Filings to Aug 2026

0 new, 0 added, 0 trimmed, 0 sold out — net +0.00 L shares (+0.0%).

Held by funds
₹75 Cr
1 schemes
Biggest holder
Nippon India Small Cap Fund
₹75 Cr · 0.1% of that fund
SchemeHoldingLast month
Nippon India Small Cap Fund Nippon India Mutual Fund₹75 Crheld

HDFC, Nippon India and SBI schemes, from their monthly disclosures. Changes are counted in shares, so a price move never looks like buying or selling.

Mutual funds Aug 2026

0 added, 0 trimmed — net 0 shares (+0.0%)

Funds are sitting on
+523%
vs est. average cost
Held by funds
₹75 Cr
1 schemes · ≈ 1.4% of the company

Shares held by these funds −61%

Aug '23 1.48 cr shares Jul '26

What the price assumes

Growth trap

To justify its price of ₹58, this stock must grow earnings at 30% every year for 7 years. Our analysis caps realistic growth at ~12%. At that growth it is worth ₹23 — downside of 61%.

Growth the price implies
30.4% a year
for 7 years, fading to 4%
It has actually compounded at
12.0% a year
net profit, FY23–FY26
The gap
0.2 pp
-61% downside if it only repeats history
Price today ₹57.72 Value at the reference growth ₹22.57

Change the assumptions yourself →

All earnings calls (7)

Read the Q1 FY27 call →